PCSK9 Inhibitors and Alzheimer's Disease

Join Dr. Mike Stone and Dr. Mike Mallin in this episode of the podcast as they explore why traditional measures of cholesterol aren't enough. Listeners will learn about the limitations of traditional cholesterol testing.  We’ll explain why this approach can be misleading and how it fails to take into account important factors such as particle size and number.

Throughout the episode, the doctors outline approaches to treatment based on ApoB testing results, including lifestyle changes, reducing insulin resistance, and medication options. They discuss the importance of personalized treatment plans and the role of ApoB testing in guiding these plans.